Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
José Rodríguez(The University of Texas MD Anderson Cancer Center), E. Condé(University of Bern), Armando López‐Guillermo(Barcelona Supercomputing Center), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), Jorge Sierra(Universitat Autònoma de Barcelona), M. Gandarillas(Marqués de Valdecilla University Hospital), Enric Carreras(Josep Carreras Leukaemia Research Institute), J. Rifón(Clinica Universidad de Navarra), J Zuazu(Institut Català d'Oncologia), Isidro Jarque(Hospital Universitari i Politècnic La Fe), Agathe León(Hospital Clínic de Barcelona), Alberto Fernández de Sevilla(Duran i Reynals Hospital), Carlos Solano(Hospital Clínico Universitario de Valencia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), J. Marín, José García‐Laraña, Carmen Albó(Spanish National Centre for Cardiovascular Research), Josè Antonio Pérez-Simón(Instituto de Biomedicina de Sevilla), Marı́a Dolores Caballero(Complejo Hospitalario de Salamanca), Antonio Gutiérrez(Hospital Universitario Son Dureta), R. Arranz(Hospital Universitario de La Princesa), Rosario Varela(Complexo Hospitalario Universitario A Coruña)
Cited by 51
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k